×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Ovarian Carcinoma
0.500
GeneticVariation
BEFREE
Mutations at the p53 tumor suppressor gene locus are a frequent genetic alteration associated with human ovarian carcinoma .
8005584 1994
×
Entrez Id: 324
Gene Symbol: APC
APC
Ovarian Carcinoma
0.010
Biomarker
BEFREE
The APC gene was studied in 40 ovarian tumours, including all the OC s showing LOH, by single-strand conformation polymorphism (SSCP).
8019564 1994
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Ovarian Carcinoma
0.400
AlteredExpression
BEFREE
We have previously found that the ovarian carcinoma cell line SK-OV-3 overexpresses c-erbB-2 /neu mRNA.
8094034 1993
×
Entrez Id: 51182
Gene Symbol: HSPA14
HSPA14
Ovarian Carcinoma
0.010
GeneticVariation
BEFREE
The expression of the 60-kDa heat-shock protein (HSP60 ) varies markedly among patients with ovarian carcinoma , and high-level expression predicts poor survival in such patients treated with cisplatin (DDP)-containing chemotherapy programs.
8100743 1993
×
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
Ovarian Carcinoma
0.500
GeneticVariation
BEFREE
It is not yet known how frequently somatic BRCA1 mutations predispose to breast and ovarian carcinoma in the general female population.
8173065 1993
×
Entrez Id: 2348
Gene Symbol: FOLR1
FOLR1
Ovarian Carcinoma
0.030
Biomarker
BEFREE
This molecule is a high affinity folate binding protein (FBP ) and a potential marker for ovarian carcinoma .
8242637 1993
×
Entrez Id: 94025
Gene Symbol: MUC16
MUC16
Ovarian Carcinoma
0.100
Biomarker
BEFREE
CA 125 remains the best tumour marker for ovarian carcinoma .8312203 1993
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Ovarian Carcinoma
0.400
Biomarker
BEFREE
The amplification rate of C-myc, C-N-ras, C-Ki-ras and C-erbB-2 in ovarian carcinoma were 50%, 44%, 31% and 25% respectively.
8585978 1995
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Ovarian Carcinoma
0.500
AlteredExpression
BEFREE
The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma .
8616869 1996
×
Entrez Id: 596
Gene Symbol: BCL2
BCL2
Ovarian Carcinoma
0.050
AlteredExpression
BEFREE
The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma .
8616869 1996
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Ovarian Carcinoma
0.500
GeneticVariation
BEFREE
These findings demonstrate the potential of the p53 tumor suppressor gene therapy in human ovarian carcinoma .
8622881 1996
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Ovarian Carcinoma
0.500
Biomarker
BEFREE
In conclusion, the present results are consistent with a role of p53 as a determinant of chemosensitivity of ovarian carcinoma .
8630996 1996
×
Entrez Id: 1026
Gene Symbol: CDKN1A
CDKN1A
Ovarian Carcinoma
0.020
GeneticVariation
BEFREE
In addition, no association was demonstrable between a polymorphism in a conserved region of the WAF1 /CIP1 gene and ovarian carcinoma .
8645586 1996
×
Entrez Id: 56996
Gene Symbol: SLC12A9
SLC12A9
Ovarian Carcinoma
0.020
GeneticVariation
BEFREE
In addition, no association was demonstrable between a polymorphism in a conserved region of the WAF1/CIP1 gene and ovarian carcinoma .
8645586 1996
×
Entrez Id: 208
Gene Symbol: AKT2
AKT2
Ovarian Carcinoma
0.310
AlteredExpression
BEFREE
In addition to AKT2 , amplification and overexpression of other yet-unidentified genes in the 19q13.1-q13.2 region may contribute to ovarian carcinoma pathogenesis or progression.
8646743 1996
×
Entrez Id: 1588
Gene Symbol: CYP19A1
CYP19A1
Ovarian Carcinoma
0.010
AlteredExpression
BEFREE
These results suggest that aromatase is expressed in stromal cells of ovarian carcinoma but not in benign ovarian neoplasms.
8686761 1996
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Ovarian Carcinoma
0.500
GeneticVariation
BEFREE
An abundance of p53 null mutations in ovarian carcinoma .
8700537 1996
×
Entrez Id: 4830
Gene Symbol: NME1
NME1
Ovarian Carcinoma
0.050
AlteredExpression
BEFREE
nm23 expression in advanced and borderline ovarian carcinoma .8702236 1996
×
Entrez Id: 94025
Gene Symbol: MUC16
MUC16
Ovarian Carcinoma
0.100
Biomarker
BEFREE
Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma : a prospective study.
8748237 1996
×
Entrez Id: 4830
Gene Symbol: NME1
NME1
Ovarian Carcinoma
0.050
AlteredExpression
BEFREE
Our results indicate that the increase of nm23 reactivity is activated in the early stages of the disease and that the progression of ovarian carcinoma is accompanied by overexpression of nm23 protein.
8900377 1996
×
Entrez Id: 861
Gene Symbol: RUNX1
RUNX1
Ovarian Carcinoma
0.010
GeneticVariation
BEFREE
Southern analyses of ovarian carcinoma cell lines showed no amplification or rearrangements involving EVI-1 .
8932329 1996
×
Entrez Id: 1236
Gene Symbol: CCR7
CCR7
Ovarian Carcinoma
0.010
GeneticVariation
BEFREE
Southern analyses of ovarian carcinoma cell lines showed no amplification or rearrangements involving EVI-1 .
8932329 1996
×
Entrez Id: 2122
Gene Symbol: MECOM
MECOM
Ovarian Carcinoma
0.010
GeneticVariation
BEFREE
Southern analyses of ovarian carcinoma cell lines showed no amplification or rearrangements involving EVI-1 .
8932329 1996
×
Entrez Id: 4609
Gene Symbol: MYC
MYC
Ovarian Carcinoma
0.010
Biomarker
BEFREE
MYC DNA amplification was seen in 33.8% (26/77 cases) of ovarian carcinoma .8972757 1996
×
Entrez Id: 3565
Gene Symbol: IL4
IL4
Ovarian Carcinoma
0.010
AlteredExpression
BEFREE
We have reported that human ovarian-carcinoma cell lines express high-affinity IL-4 receptor.
9009165 1997